摘要
目的探讨门静脉、肠系膜上静脉、脾静脉控制下进行胰腺钩突部肿瘤切除的可行性、作用和意义。方法对28例原发于胰腺钩突部的肿瘤行胰十二指肠切除。在手术中均预置门静脉、脾静脉、肠系膜上静脉阻断带。其中男性19例、女性9例。结果所有28例均成功切除肿瘤,平均手术时间4.6小时;平均出血量400毫升。无术中、术后严重并发症发生。术后中位生存时间22个月。其中12例联合血管切除,联合血管切除与单纯胰十二指肠切除组术后生存期无显著差异。结论门静脉、脾静脉、肠系膜上静脉控制下进行胰腺钩突部肿物手术治疗,可以提高手术的根治性。增加手术安全性。
Objective To explore the feasibility, significance of controlling portal vein, splenic vein and superior mesenteric vein in the resention of pancreatic uncinate process carcinoma. Methods From 1995 to 2003, pancraticoduodenectomy was performed in 28 patients who suffered from uncinate process carcinoma. Portal vein, splenic vein and superior mesenteric vein were isolated and taped respectively to control blood flow during the operation. Results AII tumors were resected successfully. The mean of operative time was 4. 6 hour and blood lose 400 ml respectively. The media survival time was 22 months. Adjunctive vein resecton was performed in 12 of 28 cases. Conclusions Control of portal, splenic and superior, mesenteric vein is a safe and effective technique for pancraticoduodenectomy for pancreatic uncinate process carcinoma.
出处
《肝胆外科杂志》
2009年第1期27-31,共5页
Journal of Hepatobiliary Surgery
关键词
钩突癌
胰十二指肠切除术
门静脉肠
系膜上静脉
脾静脉
uncinate process carcinoma
pancraticoduodeneetomy
portal vein
superior mesenteric vein
splenic vein
